Impedimed Ltd has released a press release.
AstraZeneca extends and increases HF & Renal Contract
Filed with ASX ·
Watch Impedimed's latest callImpedimed (ASX:IPD) Q1 2027 Earnings Call · Replay · Oct 29Read the transcript of Impedimed (ASX:IPD) Q1 2027 Earnings Call6ix hasn’t read this filing yet.
Earlier from Impedimed
- Share Purchase Plan Offer Booklet
- ImpediMeds Share Purchase Plan Opens
- Capital Raising Presentation
- ImpediMed Completes A$35 Million Institutional Placement
- PREVENT Trial Successful, Statistically Significant Results
Later from Impedimed
- 2021 Annual General Meeting - Chairmans Address
- AGM Presentation - November 2021
- Share Purchase Plan Successfully Completed
- PREVENT Trial Peer-Reviewed and Published
- ImpediMed Announces End Stage Renal Disease Trial Agreement
Follow Impedimed into a list and get an email when it puts out news.
Follow Impedimed